CytoMed Therapeutics Ltd. (GDTC)
0.919
0.00 (0.00%)
USD |
NASDAQ |
Oct 23, 16:00
CytoMed Therapeutics Market Cap : 10.97M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 10.97M |
| October 22, 2026 | 10.97M |
| October 21, 2026 | 10.97M |
| October 20, 2026 | 10.40M |
| October 19, 2026 | 10.17M |
| October 16, 2026 | 10.50M |
| October 15, 2026 | 10.38M |
| October 14, 2026 | 10.26M |
| October 13, 2026 | 10.38M |
| October 12, 2026 | 9.684M |
| October 09, 2026 | 10.62M |
| October 08, 2026 | 11.28M |
| October 07, 2026 | 11.70M |
| October 06, 2026 | 11.10M |
| October 05, 2026 | 12.05M |
| October 02, 2026 | 10.98M |
| October 01, 2026 | 10.74M |
| September 30, 2026 | 10.06M |
| September 29, 2026 | 10.61M |
| September 28, 2026 | 11.04M |
| September 25, 2026 | 11.40M |
| September 24, 2026 | 10.76M |
| September 23, 2026 | 10.76M |
| September 22, 2026 | 10.76M |
| September 21, 2026 | 11.47M |
| Date | Value |
|---|---|
| September 18, 2026 | 11.59M |
| September 17, 2026 | 10.48M |
| September 16, 2026 | 10.48M |
| September 15, 2026 | 9.525M |
| September 14, 2026 | 10.07M |
| September 11, 2026 | 9.247M |
| September 10, 2026 | 9.581M |
| September 09, 2026 | 9.40M |
| September 08, 2026 | 10.29M |
| September 04, 2026 | 10.19M |
| September 03, 2026 | 10.41M |
| September 02, 2026 | 10.41M |
| September 01, 2026 | 10.75M |
| August 31, 2026 | 10.75M |
| August 28, 2026 | 10.88M |
| August 27, 2026 | 11.24M |
| August 26, 2026 | 11.79M |
| August 25, 2026 | 11.06M |
| August 24, 2026 | 11.83M |
| August 21, 2026 | 12.18M |
| August 20, 2026 | 10.63M |
| August 19, 2026 | 10.65M |
| August 18, 2026 | 11.11M |
| August 17, 2026 | 10.71M |
| August 14, 2026 | 11.22M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 8.189B |
| Oncolytics Biotech, Inc. | 62.61M |
| Sangamo Therapeutics, Inc. | 47.64M |
| Sarepta Therapeutics, Inc. | 1.873B |
| Anixa Biosciences, Inc. | 103.41M |
Market Cap Related Metrics
| PS Ratio | 42.87 |
| PEG Ratio | -0.2313 |
| Price | 0.919 |
| Earnings Yield | -25.11% |
| PEGY Ratio | -0.2313 |